Up-regulation of cytochrome P450 1A2, 2C9, and 2E1 in chronic pancreatitis

Pancreas

Volumn 16, Issue 4, 1998, Pages 521-528

  Wacke, R ^a,d   Kirchner, A ^a   Prall, F ^a   Nizze, H ^a   Schmidt, W ^a   Fischer, U ^a   Nitschke, F P ^a   Adam, U ^a   Fritz, P ^b   Belloc, C ^c   Drewelow, B ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

^c INSERM   (France)

^d Department of Clinical Pharmacology   (Germany)

Author keywords

Chronic pancreatitis; Cytochrome P450 enzymes; Human pancreas; Immunohistochemistry

Indexed keywords

CYTOCHROME P450 ISOENZYME; DEALKYLVERAPAMIL; DIMETHYLNITROSAMINE DEMETHYLASE; DRUG METABOLITE; NORVERAPAMIL; PHENACETIN O DEETHYLASE; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN; VERAPAMIL;

ACINAR CELL; ADULT; AEROBIC METABOLISM; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; FEMALE; HUMAN; HUMAN TISSUE; MALE; MICROSOME; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031980167     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199805000-00011     Document Type: Article

References (38)

1. Nelson DR, Kamataki T, Waxman DJ, et al. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 1993;12:1-51.
2. Foster JR, Elcombe CR, Boobis AR, et al. Immunocytochemical localization of cytochrome P-450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody against cytochrome P-450c. Biochem Pharmacol 1986;35:4543-54.
3. Murray GI, Barnes TS, Sewell HJ, Ewen SWB, Melvin WT, Burke MD. The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450. Br J Clin Pharmacol 1988;25:465-75.
4. Anttila S, Hietanen E, Vainio H, et al. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int J Cancer 1991;47:681-5.
5. Fukui Y, Yamamoto A, Masaki R, Miyauchi K, Tashiro Y. Quantitative immunocytochemical analysis of the induction of cytochrome P450IIB in rat hepatocytes. J Histochem Cytochem 1992; 40:73-82.
6. Foster JR, Idle JR, Hardwick JP, Bars R, Scott P, Braganza JM. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J Pathol 1993;169:457-63.
7. Gonzalez FJ. Human cytochromes P450: problems and prospects. Trends Biochem Sci 1992;13:346-52.
8. Murray M. P450 enzymes: inhibition mechanisms, genetic regulation and effects of liver disease. Clin Pharmacokinet 1992;23:132-46.
9. Fischer U, Wacke R, Stange J, Nitschke FP, Adam U, Drewelow B. Rapid HPLC assay for verapamil and its metabolites: use tor application to in vitro studies. Pharmazie 1996;51:220-3.
10. Busse D, Cosme J, Beaune P, Kroemer HK, Eichelbaum M. Cytochromes of the P450 2C subfamily are the major enzymes involved in the O-demethylation of verapamil in humans. Naunyn Schmiedebergs Arch Pharmacol 1995;353:116-21.
11. Kroemer HK, Gautier JC, Beaune P, Henderson CJ, Wolf CR, Eichelbaum M. Identification of P450 enzymes involved in metabolism of verapamil in humans. Naunyn Schmiedebergs Arch Pharmacol 1993;348:332-7.
12. Eichelbaum M, Ende M, Remberg M, Schomerus M, Dengler HJ. The metabolism of DL-[14C]verapamil in man. Drug Metab Dispos 1979;7:145-8.
13. Raney KD, Shimada T, Kim DH, Groopman JD, Harris TM, Guengerich FP. Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: significance of aflatoxin Q1 as a detoxication product of aflatoxin B1. Chem Res Toxicol 1992;5:202-10.
14. Guengerich FP, Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 1991;4:1-407.
15. Ronis MJJ, Ingelman-Sundberg M. Acetone-dependent regulation of cytochrome P450j (IIE1) and P450b (IIB1) in rat liver. Xenobiotica 1989;19:1161-5.
16. Ekström G, Cronholm T, Ingelman-Sundberg M. Hydroxyl-radical production and ethanol oxidation by liver microsomes isolated from ethanol-treated rats. Biochem J 1986;233:755-61.
17. Guyan PM, Uden S, Braganza JM. Heightened free radical activity in pancreatitis. Free Radic Biol Med 1990;8:347-54.
18. Sandilands D, Jeffrey IJM, Haboubi NY, MacLennan IAM, Braganza JM. Abnormal drug metabolism in chronic pancreatitis/treatment with antioxidants. Gastroenterology 1990;98:766-72.
19. Sarr MG, Bulkley GB, Cameron JL. The role of leucocytes in the production of oxygen derived free radicals in acute experimental pancreatitis. Surgery 1987;101:2092-6.
20. Acheson DWK, Rose P, Houston JB, Braganza JM. Induction of cytochrome P-450 in pancreatic disease: consequence, coincidence or cause? Clin Chim Acta 1985;153:73-84.
21. Acheson DW, Hunt LP, Rose P, Nouston JB, Braganza JM. Factors contributing to the accelerated clearance of theophylline and antipyrine in adults with exocrine pancreatic disease. Clin Sci 1989;76:377-85.
22. Gyr KE, Singer MV, Sarles H, eds. Pancreatitis. Concepts and classification. Amsterdam: Excerpta Medica, 1984.
23. Klöppel G, Maillet B. Pathology of acute and chronic pancreatitis. Pancreas 1993;8:659-70.
24. Belloc C, Baird S, Cosme J, et al. Human cytochromes P450 expressed in Escherichia coli: production of specific antibodies. Toxicology 1996;106:207-19.
25. Schwarzmann P, Wu X, Fritz P, Tuczek HV. Histoanalyzer: a device for computer-assisted pathology. Anal Quant Cytol Histol 1992;16:71-2.
26. Ged C, Beaune P. Isolation of the human cytochrome P450 2C8 gene: multiple glucocorticoid responsive elements in the 5′ region. Biochim Biophys Acta 1991;1088:433-5.
27. Farin FM, Omiecinski CJ. Regiospecific expression of cytochrome P450s and microsomal epoxide hydrolase in human brain tissue. J Toxicol Environ Health 1993;40:317-35.
28. Kim H, Reddy S, Novak RF. 3-Methylcholanthrene and pyridine effects on CYP 1A1 and CYP 1A2 expression in rat renal tissue. Drug Metab Dispos 1995;23:818-24.
29. Mercurio MG, Sniff SJ, Halbraith RA, Sassa S. Expression of cytochrome P450 mRNAs in the colon and the rectum in normal human subjects. Biochem Biophys Res Commun 1995;210:350-5.
30. Sirica AE. Ductular hepatocytes. Histol Histopathol 1995;10:433-56.
31. Slack JMW. Developmental biology of the pancreas. Development 1995;121:1569-80.
32. Sell S, Pierece GB. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 1994;70:6-22.
33. Monis B, Valentich MA, Urrutia R, Rivolta M. Multicentric focal acinar cell hyperplasia and hepatocyte-like cell metaplasia are induced by nitrosomethylurea in rat pancreas. Int J Pancreatol 1991; 8:119-31.
34. Konishi N, Ward JM, Waalkes MP. Pancreatic hepatocytes in Fischer and Wistar rats induced by repeated injections of cadmium chloride. Toxicol Appl Pharmacol 1990;104:149-56.
35. Makino T, Usada N, Rao S, Reddy JK, Scarpelli DG. Transdifferentiation of ductular cells into hepatocytes in regenerating hamster pancreas. Lab Invest 1990;62:552-61.
36. Lieber CS. Mechanism of ethanol induced hepatic injury. Pharmacol Ther 1990;46:1-41.
37. Anderson RJ, Jeffrey IJ, Kay PM, Braganza JM. Peroxidised linolenic acid and experimental pancreatitis. Int J Pancreat 1986;1: 237-48.
38. Githens S. Glutathione metabolism in the pancreas compared with that in the liver, kidney, and small intestine. Int J Pancreatol 1991;8:97-109.